DMII

Drugs Made In America Acquisition II Corp

10.17

Sep 18 • 3:12 PM ET -0.01 (-0.05%)

10.19

Aftermarket • 4:15 PM ET +0.02 (0.20%)

Financial Shell Companies USA Small NASD

Index	-
Market Cap	647.83M
Enterprise Value	648.11M
Income	13.02M
Sales	0.00M
Book/sh	7.79
Cash/sh	0.00
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	2
IPO	Dec 03, 2025

P/E	49.95
Forward P/E	-
PEG	-
P/S	-
P/B	1.31
P/C	3810.76
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.34
Current Ratio	0.34
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	0.20
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	11600.00%
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	22.15%
Insider Trans	0.00%
Inst Own	71.49%
Inst Trans	-
ROA	5.06%
ROE	5.25%
ROIC	2.62%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	0.11%
SMA50	0.48%
SMA200	1.50%
Trades

Shs Outstand	63.70M
Shs Float	49.59M
Short Float	0.24%
Short Ratio	1.37
Short Interest	0.12M
52W High	10.21 -0.39%
52W Low	9.86 3.14%
Volatility	0.13% 0.17%
ATR (14)	0.02
RSI (14)	59.15
Beta	-
Rel Volume	1.76
Avg Volume	87.34K
Volume	153,561

Perf Week	0.07%
Perf Month	0.49%
Perf Quarter	0.69%
Perf Half Y	2.11%
Perf YTD	2.73%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	10.18
Price	10.17
Change %	-0.05%

Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in New York, NY.

Chief Executive OfficerMr. Roger Bendelac

DMAA Drugs Made In America Acquisition Corp daily Stock Chart

Index	-
Market Cap	263.16M
Enterprise Value	264.09M
Income	6.09M
Sales	0.00M
Book/sh	5.67
Cash/sh	0.00
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	2
IPO	Feb 25, 2025

P/E	58.28
Forward P/E	-
PEG	-
P/S	-
P/B	1.91
P/C	13158.00
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.02
Current Ratio	0.02
Debt/Eq	0.01
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	0.19
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	89.22%
Sales Y/Y TTM	-
EPS Q/Q	-18.01%
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	23.57%
Insider Trans	0.00%
Inst Own	49.30%
Inst Trans	-
ROA	3.18%
ROE	3.33%
ROIC	4.42%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	0.52%
SMA50	1.13%
SMA200	3.03%
Trades

Shs Outstand	24.28M
Shs Float	18.56M
Short Float	0.43%
Short Ratio	1.81
Short Interest	0.08M
52W High	10.85 -0.14%
52W Low	10.26 5.65%
Volatility	0.20% 0.15%
ATR (14)	0.02
RSI (14)	83.53
Beta	0.01
Rel Volume	0.01
Avg Volume	43.84K
Volume	352

Perf Week	0.37%
Perf Month	1.12%
Perf Quarter	1.98%
Perf Half Y	3.53%
Perf YTD	4.49%
Perf Year	5.45%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	10.84
Price	10.84
Change %	0.00%

Drugs Made In America Acquisition Corp. is a blank check company, which was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on May 23, 2024 and is headquartered in New York, NY.

Chief Executive OfficerMr. Roger Bendelac

DMII

Drugs Made In America Acquisition II Corp

DMAA

Drugs Made In America Acquisition Corp

Upgrade your Finviz experience